We are live on ! Find out more
CBT

CoreFirst Bank & Trust Portfolio holdings

AUM $189M
1-Year Est. Return 19.48%
This Fund
S&P 500
This Quarter Est. Return
+1.68%
1 Year Est. Return
+19.48%
3 Year Est. Return
+53.44%
5 Year Est. Return
+76.29%
10 Year Est. Return
AUM
$149M
AUM Growth
-$11.3M
Cap. Flow
-$12.7M
Cap. Flow %
-8.52%
Top 10 Hldgs %
39.18%
Holding
357
New
2
Increased
19
Reduced
63
Closed
235

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$526K
2
AAPL icon
Apple
AAPL
+$521K
3
CL icon
Colgate-Palmolive
CL
+$410K
4
CSX icon
CSX Corp
CSX
+$276K
5
NEE icon
NextEra Energy
NEE
+$243K

Sector Composition

Rank Sector Weight
1 Consumer Staples 15.37%
2 Technology 13.81%
3 Healthcare 7.76%
4 Energy 5.22%
5 Financials 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUM icon
351
Yum! Brands
YUM
$42.1B
-580
Closed -$80.4K
YUMC icon
352
Yum China
YUMC
$15.8B
-267
Closed -$10.6K
ZBH icon
353
Zimmer Biomet
ZBH
$18.7B
-1,252
Closed -$165K
SUM
354
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-2,651
Closed -$118K
PXD
355
DELISTED
Pioneer Natural Resource Co.
PXD
-845
Closed -$222K
NS
356
DELISTED
NuStar Energy L.P.
NS
-114
Closed -$2.65K

Similar funds

CoreFirst Bank & Trust's Q2 2024 Portfolio in Review

As of Q2 2024, CoreFirst Bank & Trust held 357 positions worth $149M, down 7.1% from $160M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

CoreFirst Bank & Trust withdrew a net $12.7M in Q2 2024, closing 235 positions and reducing 63 holdings. Its most notable exit was CSX Corp, an estimated $276K position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, CoreFirst Bank & Trust opened a new position in FT Vest US Equity Deep Buffer ETF June worth $342K.

  • CoreFirst Bank & Trust's largest Q2 2024 buy was FT Vest US Equity Deep Buffer ETF June: 8,365 shares worth $342K.
  • CoreFirst Bank & Trust added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $1.23M increase.
  • CoreFirst Bank & Trust's biggest Q2 2024 reduction was Pfizer, cutting an estimated $526K.
  • CoreFirst Bank & Trust fully exited CSX Corp in Q2 2024, selling an estimated $276K.
  • CoreFirst Bank & Trust's ten largest holdings make up 39% of its $149M portfolio in Q2 2024.
  • CoreFirst Bank & Trust opened 2 new positions and closed 235 in Q2 2024.
  • CoreFirst Bank & Trust's portfolio value fell 7.1% quarter-over-quarter to $149M.

Based on CoreFirst Bank & Trust's 13F filing for Q2 2024, filed 14 Aug 2024.